Published in Hepatitis Weekly, August 24th, 2009
"Seroprevalence was 0.86% for HCV (n = 7) and 0. 12% for HBV (n = 1). HCV-related arthritis was diagnosed in 4 (0.5%) patients; no patient had HBV-related arthritis. HCV-seropositive patients had significantly higher transaminase levels (ALAT, 41.5 IU vs 23.2 IU. p = 0.02 and ASAT, 39.2 IU vs 21.8 IU, p = 0.001) but only 2 patients had...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.